Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Copeptin assessment to predict vasoplegia after cardiopulmonary by-pass. An observational cohort study.

View through CrossRef
Abstract Background Post-cardiotomy vasoplegic syndrome is a vasodilatory shock characterized by a decrease of vascular tone with a normal or increased cardiac output. A relative deficit in vasopressin secretion in the postoperative was hypothesized. Copeptin is secreted in equimolar ratio with vasopressin but it is more stable and easier to measure. The aim of the present study was to investigate whether perioperative copeptin was associated with post-cardiotomy vasoplegic syndrome. Methods All patients scheduled for cardiac surgery were evaluated. Exclusion criteria were age < 18 years old, corticosteroids therapy, heart transplantation, extra-circulatory life support, sepsis, preoperative use of vasoactive drugs, off-pump surgery, chronic hepatic and renal failure, paraneoplastic syndrome, lack of informed consent. Post-cardiotomy vasoplegic syndrome was defined as a mean arterial pressure < 60 mmHg, a reduction of systemic vascular resistances < 1200 dyn*s/cm 5 *m 2 and/or the need of nor-epinephrine ³ 0.1 µg/kg/min. All patients underwent a preoperative evaluation of the corticotropin stimulation test; then, before surgery (T0), on day one after surgery (T1) and after 7 days (T2) copeptin and NT-proBNP concentration were measured. Results Among 55 enrolled patients, 9 (16.3%) developed post-cardiac surgery vasoplegia. Patients with vasoplegia had higher preoperative level of copeptin (19.2 pmol/L, IQR 17.89 – 21.29 vs 11.39 pmol/L, IQR 6.33 - 14.78; p < 0.001) and NT-proBNP (1435 pg/ml, IQR 721.75 – 1836.25 vs 365.5 pg/ml, IQR 141 - 977); p = 0.006) compared to the control group. At the multivariable analysis, preoperative copeptin resulted a significant predictor of vasoplegia (OR 1.56, 95% CI 1.002-1.33) and the ROC analysis showed an accurate copeptin cut off able to identify vasoplegic patients (> 16.9 pmol/L, AUC = 0.86, 95% CI 0.73-0.94). Otherwise, a lack of response to the low dose corticotropin test was not a predictor of PCVS; no patient presented a pathological response to the standard dose test. ConclusionsIncreased preoperative copeptin and NT-proBNP levels might be associated with an increased risk to develop post-cardiotomy vasoplegic syndrome. Our results suggest that patients with a decompensated neuroendocrine control of cardiovascular function are more prone to develop postoperative vasoplegia.
Title: Copeptin assessment to predict vasoplegia after cardiopulmonary by-pass. An observational cohort study.
Description:
Abstract Background Post-cardiotomy vasoplegic syndrome is a vasodilatory shock characterized by a decrease of vascular tone with a normal or increased cardiac output.
A relative deficit in vasopressin secretion in the postoperative was hypothesized.
Copeptin is secreted in equimolar ratio with vasopressin but it is more stable and easier to measure.
The aim of the present study was to investigate whether perioperative copeptin was associated with post-cardiotomy vasoplegic syndrome.
Methods All patients scheduled for cardiac surgery were evaluated.
Exclusion criteria were age < 18 years old, corticosteroids therapy, heart transplantation, extra-circulatory life support, sepsis, preoperative use of vasoactive drugs, off-pump surgery, chronic hepatic and renal failure, paraneoplastic syndrome, lack of informed consent.
Post-cardiotomy vasoplegic syndrome was defined as a mean arterial pressure < 60 mmHg, a reduction of systemic vascular resistances < 1200 dyn*s/cm 5 *m 2 and/or the need of nor-epinephrine ³ 0.
1 µg/kg/min.
All patients underwent a preoperative evaluation of the corticotropin stimulation test; then, before surgery (T0), on day one after surgery (T1) and after 7 days (T2) copeptin and NT-proBNP concentration were measured.
Results Among 55 enrolled patients, 9 (16.
3%) developed post-cardiac surgery vasoplegia.
Patients with vasoplegia had higher preoperative level of copeptin (19.
2 pmol/L, IQR 17.
89 – 21.
29 vs 11.
39 pmol/L, IQR 6.
33 - 14.
78; p < 0.
001) and NT-proBNP (1435 pg/ml, IQR 721.
75 – 1836.
25 vs 365.
5 pg/ml, IQR 141 - 977); p = 0.
006) compared to the control group.
At the multivariable analysis, preoperative copeptin resulted a significant predictor of vasoplegia (OR 1.
56, 95% CI 1.
002-1.
33) and the ROC analysis showed an accurate copeptin cut off able to identify vasoplegic patients (> 16.
9 pmol/L, AUC = 0.
86, 95% CI 0.
73-0.
94).
Otherwise, a lack of response to the low dose corticotropin test was not a predictor of PCVS; no patient presented a pathological response to the standard dose test.
ConclusionsIncreased preoperative copeptin and NT-proBNP levels might be associated with an increased risk to develop post-cardiotomy vasoplegic syndrome.
Our results suggest that patients with a decompensated neuroendocrine control of cardiovascular function are more prone to develop postoperative vasoplegia.

Related Results

Definitions for Vasoplegia Associated With On-Pump Cardiac Surgery: A Systematic Review With Meta-Analysis
Definitions for Vasoplegia Associated With On-Pump Cardiac Surgery: A Systematic Review With Meta-Analysis
OBJECTIVES: Vasoplegia is a common complication of cardiac surgery that uses cardiopulmonary bypass and contributes to morbidity and mortality, yet a consensus ...
Non-dipper ve Dipper Hipertansiyonlu Hastalardaki Copeptin Düzeyinin Karşılaştırması
Non-dipper ve Dipper Hipertansiyonlu Hastalardaki Copeptin Düzeyinin Karşılaştırması
Amaç: Kardiyovasküler hastalıklar açısından hipertansiyon önemli bir risk faktörüdür. Amblatuvar kan basıncı monitörizasyonu(AKBM) ile yapılan çalışmalar kan basıncının gün içeris...
Post cardiac surgery vasoplegia is associated with high preoperative copeptin plasma concentration
Post cardiac surgery vasoplegia is associated with high preoperative copeptin plasma concentration
Abstract Introduction Post cardiac surgery vasodilatation (PCSV) is possibly related to a vasopressin deficiency that could relate t...
Assessment of copeptin and obestatin levels in coronary artery disease patients
Assessment of copeptin and obestatin levels in coronary artery disease patients
Abstract Background Acute coronary syndrome (ACS) is classified into acute myocardial infarction (AMI), and unstable angina (UA). They are curren...
Clinical study of copeptin in serum patiants of heart diseases
Clinical study of copeptin in serum patiants of heart diseases
The study  included the estimation  copeptin level  in serum of healthy and  patients  with heart diseases .  The Results indicated that the level of copeptin in serum was (36.2±1....
Copeptin: A Novel Marker for Diagnosis and Prognosis of Various Diseases AssociatedWith Diabetes
Copeptin: A Novel Marker for Diagnosis and Prognosis of Various Diseases AssociatedWith Diabetes
Copeptin is an arginine vasopressin (AVP) precursor whose C-terminal has evolved into 39 amino acids. This AVP precursor is converted into equimolar amounts of Copeptin, neurophysi...
Copeptin: a novel marker for diagnosis and prognosisof various diseases associated with diabetes
Copeptin: a novel marker for diagnosis and prognosisof various diseases associated with diabetes
Copeptin is an arginine vasopressin (AVP) precursor whose C-terminal has evolved into 39 amino acids. This AVPprecursor is converted into equimolar amounts of copeptin, neurophysin...

Back to Top